Free Trial

AirSculpt Technologies (AIRS) Competitors

AirSculpt Technologies logo
$3.01 +0.75 (+33.32%)
As of 11:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AIRS vs. CELC, EHAB, INNV, PSNL, VMD, LFMD, DCGO, TOI, SERA, and CORBF

Should you be buying AirSculpt Technologies stock or one of its competitors? The main competitors of AirSculpt Technologies include Celcuity (CELC), Enhabit (EHAB), InnovAge (INNV), Personalis (PSNL), Viemed Healthcare (VMD), LifeMD (LFMD), DocGo (DCGO), Oncology Institute (TOI), Sera Prognostics (SERA), and Global Cord Blood (CORBF). These companies are all part of the "healthcare" industry.

AirSculpt Technologies vs.

Celcuity (NASDAQ:CELC) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

AirSculpt Technologies has higher revenue and earnings than Celcuity. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$63.78M-$2.81-3.84
AirSculpt Technologies$180.35M0.73-$4.48M-$0.15-15.07

Celcuity has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500.

Celcuity presently has a consensus price target of $30.17, indicating a potential upside of 179.32%. AirSculpt Technologies has a consensus price target of $3.75, indicating a potential upside of 65.93%. Given Celcuity's stronger consensus rating and higher probable upside, equities research analysts plainly believe Celcuity is more favorable than AirSculpt Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
AirSculpt Technologies
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Celcuity received 330 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 67.79% of users gave Celcuity an outperform vote while only 35.48% of users gave AirSculpt Technologies an outperform vote.

CompanyUnderperformOutperform
CelcuityOutperform Votes
341
67.79%
Underperform Votes
162
32.21%
AirSculpt TechnologiesOutperform Votes
11
35.48%
Underperform Votes
20
64.52%

63.3% of Celcuity shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 15.8% of Celcuity shares are held by insiders. Comparatively, 76.6% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Celcuity had 3 more articles in the media than AirSculpt Technologies. MarketBeat recorded 7 mentions for Celcuity and 4 mentions for AirSculpt Technologies. Celcuity's average media sentiment score of 1.36 beat AirSculpt Technologies' score of 0.47 indicating that Celcuity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AirSculpt Technologies
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Celcuity has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -4.13%. AirSculpt Technologies' return on equity of 2.22% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -62.66% -39.78%
AirSculpt Technologies -4.13%2.22%0.90%

Summary

Celcuity beats AirSculpt Technologies on 10 of the 18 factors compared between the two stocks.

Get AirSculpt Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIRS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIRS vs. The Competition

MetricAirSculpt TechnologiesOffices & clinics of medical doctors IndustryBusiness SectorNASDAQ Exchange
Market Cap$132.38M$1.21B$22.15B$7.93B
Dividend YieldN/AN/A2.59%4.22%
P/E Ratio-16.1420.2730.7118.54
Price / Sales0.731.24171.49103.29
Price / Cash25.1536.0131.5134.62
Price / Book1.5511.205.024.25
Net Income-$4.48M-$52.07M$194.53M$248.18M
7 Day Performance15.31%6.80%0.23%1.03%
1 Month Performance7.62%22.20%2.48%2.70%
1 Year Performance-58.91%16.98%11.15%4.05%

AirSculpt Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIRS
AirSculpt Technologies
1.5722 of 5 stars
$3.01
+33.3%
$3.75
+24.5%
-59.0%$173.91M$180.35M-21.21240Earnings Report
News Coverage
Gap Up
High Trading Volume
CELC
Celcuity
2.6444 of 5 stars
$10.45
+2.1%
$30.17
+188.7%
-33.7%$395.42MN/A-4.0040Short Interest ↓
Analyst Revision
News Coverage
EHAB
Enhabit
1.5476 of 5 stars
$7.24
-5.7%
$8.50
+17.4%
-22.8%$365.48M$1.03B-3.1210,900Upcoming Earnings
News Coverage
Positive News
INNV
InnovAge
1.3841 of 5 stars
$2.67
-2.9%
$5.00
+87.3%
-23.2%$361.10M$806.61M-14.052,000Upcoming Earnings
News Coverage
Gap Down
PSNL
Personalis
3.6262 of 5 stars
$3.16
-0.9%
$7.80
+146.8%
+149.0%$279.05M$84.61M-1.88400Upcoming Earnings
News Coverage
Positive News
VMD
Viemed Healthcare
1.7505 of 5 stars
$6.61
-0.3%
N/A-15.4%$261.24M$224.26M24.48630Upcoming Earnings
Short Interest ↓
Positive News
LFMD
LifeMD
2.4098 of 5 stars
$5.39
-0.7%
$11.43
+112.0%
-36.1%$240.31M$212.45M-8.42230Upcoming Earnings
Analyst Forecast
Insider Trade
Options Volume
News Coverage
Gap Down
DCGO
DocGo
2.5149 of 5 stars
$2.07
-2.4%
$4.89
+136.3%
-35.1%$211.11M$616.56M7.392,920Upcoming Earnings
Positive News
TOI
Oncology Institute
0.8102 of 5 stars
$2.39
+10.6%
N/A+149.1%$180.59M$393.41M-3.06660News Coverage
SERA
Sera Prognostics
1.0624 of 5 stars
$3.39
-0.3%
N/A-71.9%$127.68M$77,000.00-3.42120Short Interest ↓
Gap Down
CORBF
Global Cord Blood
N/A$0.95
+46.2%
N/AN/A$115.47M$196.12M0.001,200Gap Up

Related Companies and Tools


This page (NASDAQ:AIRS) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners